Northern Ireland allows year-round GP flu antivirals

From 1 May 2026, GPs in Northern Ireland will be able to prescribe flu antivirals all year rather than waiting for an official notice that influenza is “in circulation”. The Department of Health’s Statutory Rule 2026 No. 72 amends the 2004 GP prescribing regulations to make this possible. The Assembly’s Committee for Health considered the proposal on 26 March 2026 after a short consultation in February–March. (consult.nia-yourassembly.org.uk)

What actually changed is simple: the “notification” step has been removed for two medicines - oseltamivir (Tamiflu) and zanamivir (Relenza). Until now, routine NHS prescribing was tied to a formal alert from health officials confirming flu transmission in the community. The new rule lifts that trigger so clinicians can prescribe year‑round when a patient meets the clinical criteria already set out in the GP contract regulations. Those underlying criteria in Schedule 2 still apply. (legislation.gov.uk)

Why make this shift now? Flu doesn’t always keep to winter. Public health teams in Northern Ireland track respiratory infections throughout the year and still see off‑season activity, especially in care settings. Removing the red‑tape step helps GPs and prescribers act faster when outbreaks appear outside the usual months. (publichealth.hscni.net)

If you’re a patient, this does not mean “Tamiflu for everyone”. It means your GP no longer has to wait for a seasonal announcement before prescribing if you’re in an at‑risk group or there’s a clinical reason to treat or prevent flu. The decision will still be based on your symptoms, timing, medical history and current guidance. If you start to feel unwell, contact your GP practice promptly so they can advise you.

If you’re a GP or practice nurse, treat this as a green light to update protocols rather than a licence for blanket prescribing. The change removes the need for a CMO/Department notification; it doesn’t change product licences or the existing eligibility rules in the 2004 regulations. Check your practice templates, outbreak pathways for care homes, and local sign‑off processes so you can act quickly when needed. (legislation.gov.uk)

Community pharmacists will want to prepare too. Stock planning for oral oseltamivir and inhaled zanamivir across the year will help avoid delays during off‑season outbreaks, and teams should keep an eye on any Drug Tariff or reimbursement updates issued by the Business Services Organisation (BSO). (bso.hscni.net)

This move also lines up with changes seen elsewhere in the UK over the past year, where national bodies removed similar restrictions so high‑risk patients could receive antivirals at any time of year. For Northern Ireland readers, that context matters: it signals a UK‑wide effort to make access quicker while keeping prescribing targeted. (pharmaceutical-journal.com)

Let’s talk impact. Faster access can limit outbreaks in schools, universities and care homes, and may reduce complications for people at higher risk. At the same time, good stewardship remains essential to protect effectiveness. That balance - access and stewardship - is at the heart of responsible prescribing, and public health teams will continue to monitor flu patterns across the year. (publichealth.hscni.net)

The practical backdrop is a busy medicines system. BSO data show Northern Ireland processed around 2.2 million prescription forms per month in 2024/25, and had the highest ingredient cost per person in the UK at just over £262. Enabling timely, appropriate flu treatment sits within that wider picture of demand, resources and careful use of medicines. (health-ni.gov.uk)

For your media‑literacy toolkit: older committee evidence explains why restrictions existed in the first place - to avoid overuse and resistance. Today’s change removes an administrative trigger, not the clinical safeguards. When you read headlines about “year‑round Tamiflu”, remember it still means “for the right patient, at the right time”. (niassembly.gov.uk)